The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

VOV.VN - The Ho Chi Minh City Department of Health has withdrawn 70 registrations for medical devices after uncovering ...

The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

Wells Bio Co., Ltd.'(CEO Lee Min-jeon), a subsidiary of the global in vitro diagnostic company 'Access Bio', announced on the ...

Revvity, Inc. (NYSE: RVTY), today announced the launch of its new IDS i20™ analytical random access platform from EUROIMMUN, ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

In this Fierce Biotech discussion, Chris Hayden speaks with Arnon Chait, PhD, co-founder and CEO of Cleveland Diagnostics, and Tyler Allchin, managing director of healthcare at JobsOhio. | Cleveland ...

The EnVisio X1 In-Body Spatial Intelligence System from the Eden Prairie provides real-time 3D guidance for tracking surgical ...